Tag: Monsanto

Understanding the legal implications of the California jury decision on glyphosate

Glyphosate — commonly known as Roundup — suffered a blow in the court of public opinion following a California jury decision last week, but the actual legal implications of the verdict are still to be determined in court. The jury found Monsanto liable in a case where former school groundskeeper Dewayne Johnson alleges exposure to… Read more »

BASF to sell Clearfield canola system as a condition for acquiring LibertyLink

The ripple effect from Bayer’s acquisition of Monsanto continues in the canola seed business. Canada’s Competition Bureau says it has approved BASF’s purchase of Bayer’s LibertyLink canola system on the condition that BASF sell its own Clearfield production system for canola. “The Commissioner of Competition concluded that BASF’s acquisition of the Bayer assets would likely… Read more »

Corteva, Monsanto reach deal to sell Xtend soybeans under new Brevant brand

Monsanto and Corteva Agriscience — the newly-named agriculture division of DowDuPont — say they have reached a licensing agreement that clears the way for Corteva to offer Roundup Ready 2 Xtend soybeans under its new Brevant seed brand in Canada. The non-exclusive, royalty bearing deal also allows Corteva to incorporate the stacked trait that combines… Read more »

What we know (and don’t know) so far about the GM wheat discovery in Alberta

When you look at the scope of Canadian agriculture, the discovery of a handful of wheat plants containing an unapproved genetically modified trait growing on a remote site in southern Alberta last summer is a testament to the rigour of the Canadian regulatory system. First and foremost, the Canadian Food Inspection Agency (CFIA) says none… Read more »

Unapproved GM wheat plants discovered in Alberta

Update, June 29: The CFIA has published its incident report on the discovery of unapproved GM wheat plants in southern Alberta. The agency says it determined it was an isolated case, with no wheat entering the food or feed system, but that it was unable to determine where it came from: “The CFIA in cooperation with… Read more »

Bayer closes acquisition of Monsanto

It’s a done deal. Monsanto shares are no longer trading on the New York Stock Exchange, as Bayer completed its US$63 billion acquisition of Monsanto on Thursday. The actual integration of Monsanto into Bayer — and the coinciding retirement of the Monsanto name — won’t happen immediately, as approval from the U.S. Department of Justice… Read more »

Poll: Is it positive for the GMO debate for Bayer to retire the name Monsanto?

The name Monsanto is headed for retirement. Bayer has confirmed it will no longer use the name after it closes its US$63 billion acquisition of Monsanto. Monsanto has been the target of anti-GMO activists for years, serving as a corporate lightning rod for critics of genetic modification and crop protection technology in general. Whether referenced… Read more »

Monsanto name to become part of history, with acquisition by Bayer set to close on Thursday

One of the most well-known and controversial brands in the world will soon become part of history. Bayer has confirmed it plans to complete its acquisition of Monsanto on June 7, after receiving all the required regulatory approvals. Monsanto products will retain their brand names under Bayer’s portfolio, but the name “Monsanto” will be retired…. Read more »

Bayer-Monsanto deal receives green light from Canada’s Competition Bureau

Canada’s competition regulator says it has reached an agreement with Bayer that lays out the conditions for its proposed acquisition of Monsanto. The announcement comes a day after the U.S. Department of Justice gave its conditional approval to the US$66 billion deal. The Competition Bureau concluded that the deal “would likely substantially lessen and prevent… Read more »

Canadian Competition Bureau still reviewing Bayer-Monsanto deal

With the European Union granting its conditional approval in late March, and U.S. antitrust authorities reportedly set to give their thumbs-up signal, Canada’s competition regulator has yet to issue its decision on Bayer’s proposed acquisition of Monsanto. The US$66 billion deal, which was originally announced in September 2016, has significant implications in the Canadian market,… Read more »

Monsanto BioAg BioAdvantage Trial – 2017 results

The third year of Monsanto BioAg’s BioAdvantage Trials (BAT) wrapped up with a morning event that had co-operators, agronomists, and reps feeling optimistic for the growing season to come. The event was held in Saskatoon, the home of partner brand Novozymes’ headquarters and a hub for Western Canadian Ag. The event would update attendees on… Read more »

Bayer planning to sell digital farming business to BASF

Bayer has confirmed it will be selling its digital farming business to gain approval of its acquisition of Monsanto instead of licensing the digital assets out to a competing company. In gaining regulatory approval of the deal in Europe, Bayer had agreed to license its digital farming package to BASF. However, in a statement shared… Read more »

Bayer gains EU approval to acquire Monsanto

Bayer has checked off one of the final boxes on the list of approvals needed for its acquisition of Monsanto, as the European Commission granted conditional approval of the $66 billion deal on Wednesday. “We have approved Bayer’s plans to take over Monsanto because the parties’ remedies, worth well over €6 billion, meet our competition… Read more »

Monsanto planning to expand dicamba platform in soybeans, canola

Monsanto plans to expand its Xtend herbicide tolerance package, which combines tolerance to dicamba and glyphosate, in the coming years, adding other herbicide-tolerance traits, and introducing it to new crops, including canola. Monsanto, subsidiary The Climate Corporation, and The BioAg Alliance — Monsanto’s collaboration with Novozymes — shared their annual innovation pipeline updates in conjunction… Read more »

Bayer signs C$8.7 billion deal to sell LibertyLink and seed businesses to BASF

Bayer has signed an agreement to divest some of its crop business to BASF for €5.9 billion (approximately C$8.7 billion) to gain regulatory approval for Bayer’s planned acquisition of Monsanto. The transaction with BASF includes Bayer’s global glufosinate-ammonium business and the related LibertyLink herbicide tolerance technology. BASF is also marking its entry into the seed… Read more »